| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 03/28/2002 | US20020037875 Antiinflammatory agents; antitumor agent |
| 03/28/2002 | US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | CA2423262A1 Resorcinol derivatives |
| 03/21/2002 | WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/21/2002 | WO2002022562A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | WO2002022559A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | CA2420007A1 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/20/2002 | EP0944587B1 Metalloproteinase inhibitors |
| 03/19/2002 | US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc. |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/14/2002 | WO2002019967A2 Substituted hydrazine derivatives |
| 03/14/2002 | WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 03/14/2002 | WO2001058852A3 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 03/14/2002 | CA2422198A1 Substituted hydrazine derivatives |
| 03/13/2002 | EP0958276B1 Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect |
| 03/13/2002 | EP0770067B1 Substituted cinnamic oxime and hydroxamide derivatives |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | CA2032581C Hydrolytically degradable hydrophilic gels and the method for preparation thereof |
| 03/07/2002 | WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002018319A1 Process for making n-aryl-anthranilic acids and their derivatives |
| 03/07/2002 | CA2420003A1 Process for making n-aryl-anthranilic acids and their derivatives |
| 02/27/2002 | EP1181267A1 Halogen compounds |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1079789C Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same |
| 02/26/2002 | US6350907 Matrix metalloprotease inhibitors |
| 02/26/2002 | US6350902 Process for the selective N-formylation of N-hydroxylamines |
| 02/19/2002 | US6348597 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines |
| 02/14/2002 | WO2002012220A2 Process for preparing discodermolide and analogues thereof |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | US20020019430 Nervous system and psychological disorders |
| 02/14/2002 | CA2418895A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/13/2002 | EP1179529A1 Novel hydroxamic acid derivatives |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/07/2002 | WO2002010122A1 Preparation of fatty hydroxamate |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/06/2002 | EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/05/2002 | US6344457 Rheumatoid arthritis, osteoarthritis, osteoporosis, corneal ulceration, periodontitis, gingivitis or tumorous invasion and metastatic proliferation, atherosclerosis, aids, chronic inflammatory diseases of the intestine |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 01/29/2002 | US6342633 O-benzyl oxime ether derivatives and their use as pesticides |
| 01/24/2002 | WO2002006213A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 01/22/2002 | US6340761 Amination and dehydrohalogenation with piperidine compounds |
| 01/17/2002 | US20020007085 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/10/2002 | US20020004608 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/08/2002 | US6337306 Herbicides for agriculture |
| 01/03/2002 | WO2002000609A2 2,6,7-substituted tetralines useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/03/2002 | WO2002000593A2 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/03/2002 | WO2002000590A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 01/03/2002 | US20020002307 Process for the selective N-formylation of N-hydroxylamines |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | CA2411162A1 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/02/2002 | EP1167346A1 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165495A1 Resorcinol derivatives |
| 01/01/2002 | CA2083149C Intermediate used for the preparation of deferoxamine |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | US20010053555 Methods for solid-phase synthesis of hydroxylamine compounds and derivatives and combinatorial libraries thereof |
| 12/20/2001 | DE10029015A1 Coagulation Factor Xa inhibitor, useful for treatment, prophylaxis or diagnosis of thromboembolic disease, comprising acylated 3- or 4-amidino-benzylamine derivative |
| 12/18/2001 | US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 12/18/2001 | CA2208585C Benzamidoxime derivative, process for production thereof, and agrohorticultural bactericide |
| 12/13/2001 | US20010051630 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses |
| 12/12/2001 | EP0851850B1 Synthesis of alpha-chloro or alpha-fluoro ketones |
| 12/11/2001 | US6329373 Metalloproteinase inhibitors |
| 12/06/2001 | WO2001092274A2 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 12/06/2001 | WO2001092273A2 Benzenedicarboxylic acid derivatives |
| 12/06/2001 | WO2001092212A1 Excitatory amino acid receptor modulators |
| 12/06/2001 | US20010049374 Amidino derivatives of quinoline and naphthalene |
| 12/06/2001 | CA2410889A1 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 12/05/2001 | EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs |
| 12/05/2001 | CN1075807C Iminooxymethylene anilides, process and intermediate products for preparing the same and pesticides containing the same |
| 11/29/2001 | WO2001090051A1 Phenylglycine derivatives |
| 11/29/2001 | US20010046953 Useful in laundry, automatic dishwashing and hard surface cleaning |
| 11/28/2001 | EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 11/27/2001 | US6323227 Prodrugs |
| 11/22/2001 | US20010044468 Reduced in the body to produce a benzamidine; nontoxic |
| 11/22/2001 | US20010044459 Hydroxamic acid derivatives |
| 11/21/2001 | EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
| 11/21/2001 | CN1323203A FC receptor modulators and uses thereof |
| 11/21/2001 | CN1075062C 乙酸衍生物 Acetic acid derivatives |
| 11/15/2001 | WO2001085170A1 Peptide deformylase inhibitors |
| 11/15/2001 | US20010041798 Processes and intermediates in the synthesis of 5-(3-{exo-bicyclo{2.2.1}hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6- tetrahydropyrimidin-2(1H)-one |
| 11/15/2001 | CA2408236A1 Peptide deformylase inhibitors |
| 11/14/2001 | CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 11/13/2001 | US6316009 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharamaceutical and cosmetic compositions containing same |
| 11/08/2001 | WO2001049657A8 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 11/06/2001 | US6313173 Glyoxylic acid amides |
| 11/06/2001 | US6313159 Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors |
| 11/06/2001 | US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals |
| 11/06/2001 | US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers |
| 11/01/2001 | WO2001080903A1 Detection and treatment of atherosclerosis based on plasma sphingomyelin concentration |
| 11/01/2001 | WO2001025187A3 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 10/31/2001 | EP1149069A1 Phenylglycine derivatives |
| 10/30/2001 | US6310245 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect |
| 10/30/2001 | US6310084 Inhibitors of metalloproteases involved in tissue degradation |
| 10/25/2001 | WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/25/2001 | WO2001078719A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |